BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 24613675)

  • 1. Black race independently predicts worse survival in uterine carcinosarcoma.
    Erickson BK; Doo DW; Zhang B; Huh WK; Leath CA
    Gynecol Oncol; 2014 May; 133(2):238-41. PubMed ID: 24613675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant radiation therapy in uterine carcinosarcoma: A population-based analysis of patient demographic and clinical characteristics, patterns of care and outcomes.
    Manzerova J; Sison CP; Gupta D; Holcomb K; Caputo TA; Parashar B; Nori D; Wernicke AG
    Gynecol Oncol; 2016 May; 141(2):225-230. PubMed ID: 26896827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stage I uterine carcinosarcoma: Matched cohort analyses for lymphadenectomy, chemotherapy, and brachytherapy.
    Seagle BL; Kanis M; Kocherginsky M; Strauss JB; Shahabi S
    Gynecol Oncol; 2017 Apr; 145(1):71-77. PubMed ID: 28317560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Adjuvant Therapy on Survival and Recurrence Patterns in Women With Early-Stage Uterine Carcinosarcoma: A Multi-institutional Study.
    Guttmann DM; Li H; Sevak P; Grover S; Jacobson G; Feldman A; Rubin S; Chu C; Bhatia S; Elshaikh MA; Lin LL
    Int J Gynecol Cancer; 2016 Jan; 26(1):141-8. PubMed ID: 26509850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multi-institutional study of outcomes in stage I-III uterine carcinosarcoma.
    Dickson EL; Vogel RI; Gehrig PA; Pierce S; Havrilesky L; Secord AA; Dottino J; Fader AN; Ricci S; Geller MA
    Gynecol Oncol; 2015 Nov; 139(2):275-82. PubMed ID: 26348313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparities in receipt of care for high-grade endometrial cancer: A National Cancer Data Base analysis.
    Bregar AJ; Alejandro Rauh-Hain J; Spencer R; Clemmer JT; Schorge JO; Rice LW; Del Carmen MG
    Gynecol Oncol; 2017 Apr; 145(1):114-121. PubMed ID: 28159409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial disparities in uterine and ovarian carcinosarcoma: A population-based analysis of treatment and survival.
    Rojas C; Tian C; Powell MA; Chan JK; Bateman NW; Conrads TP; Rocconi RP; Jones NL; Shriver CD; Hamilton CA; Maxwell GL; Casablanca Y; Darcy KM
    Gynecol Oncol; 2020 Apr; 157(1):67-77. PubMed ID: 32029291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial disparities in young women with endometrial cancer.
    Mukerji B; Baptiste C; Chen L; Tergas AI; Hou JY; Ananth CV; Neugut AI; Hershman DL; Wright JD
    Gynecol Oncol; 2018 Mar; 148(3):527-534. PubMed ID: 29307452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wilms' tumor 1 protein and estrogen receptor beta expression are associated with poor outcomes in uterine carcinosarcoma.
    Guntupalli SR; Cao D; Shroff R; Gao F; Menias C; Stewart Massad L; Powell MA; Mutch DG; Thaker PH
    Ann Surg Oncol; 2013 Jul; 20(7):2373-9. PubMed ID: 23344579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matched-pair Analysis for Survival Endpoints Between Women With Early-stage Uterine Carcinosarcoma and Uterine Serous Carcinoma.
    Yahya JB; Zhu S; Burmeister C; Hijaz MY; Elshaikh MA
    Am J Clin Oncol; 2021 Sep; 44(9):463-468. PubMed ID: 34265785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does race predict survival for women with invasive breast cancer?
    Walsh SM; Zabor EC; Stempel M; Morrow M; Gemignani ML
    Cancer; 2019 Sep; 125(18):3139-3146. PubMed ID: 31206623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disparities in adjuvant treatment of high-grade endometrial cancer in the Medicare population.
    Corey L; Cote ML; Ruterbusch JJ; Vezina A; Winer I
    Am J Obstet Gynecol; 2022 Apr; 226(4):541.e1-541.e13. PubMed ID: 34736911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of care, predictors, and outcomes of chemotherapy in elderly women with early-stage uterine carcinosarcoma: a population-based analysis.
    Garg G; Yee C; Schwartz K; Mutch DG; Morris RT; Powell MA
    Gynecol Oncol; 2014 May; 133(2):242-9. PubMed ID: 24561247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial disparities in treatment of high-grade endometrial cancer in the Medicare population.
    Rauh-Hain JA; Buskwofie A; Clemmer J; Boruta DM; Schorge JO; Del Carmen MG
    Obstet Gynecol; 2015 Apr; 125(4):843-851. PubMed ID: 25751197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial disparities in uterine clear cell carcinoma: a multi-institution study.
    Al-Wahab ZR; Kumar S; Mutch DG; Dowdy SC; Hensley SA; Wang Y; Mahdi H; Ali-Fehmi R; Morris RT; Elshaikh M; Munkarah AR
    Int J Gynecol Cancer; 2014 Mar; 24(3):541-8. PubMed ID: 24552897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological characteristics, treatment and outcomes in uterine carcinosarcoma and grade 3 endometrial cancer patients: a comparative study.
    Zhu J; Wen H; Bi R; Wu X
    J Gynecol Oncol; 2016 Mar; 27(2):e18. PubMed ID: 26463439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival after pelvic exenteration for uterine malignancy: A National Cancer Data Base study.
    Seagle BL; Dayno M; Strohl AE; Graves S; Nieves-Neira W; Shahabi S
    Gynecol Oncol; 2016 Dec; 143(3):472-478. PubMed ID: 27760707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor characteristics and outcome of uterine carcinosarcoma in women aged ≥80 years.
    Matsuo K; Ross MS; Yunokawa M; Johnson MS; Machida H; Omatsu K; Klobocista MM; Im DD; Satoh S; Baba T; Ikeda Y; Bush SH; Hasegawa K; Blake EA; Takekuma M; Shida M; Nishimura M; Adachi S; Pejovic T; Takeuchi S; Yokoyama T; Ueda Y; Iwasaki K; Miyake TM; Yanai S; Nagano T; Takano T; Shahzad MM; Ueland FR; Kelley JL; Roman LD
    Surg Oncol; 2019 Jun; 29():25-32. PubMed ID: 31196490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uterine and ovary carcinosarcomas: outcome, prognosis factors, and adjuvant therapy.
    Pacaut C; Bourmaud A; Rivoirard R; Moriceau G; Guy JB; Collard O; Bosacki C; Jacquin JP; Levy A; Chauleur C; Magné N; Merrouche Y
    Am J Clin Oncol; 2015 Jun; 38(3):272-7. PubMed ID: 23751320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials.
    Yothers G; Sargent DJ; Wolmark N; Goldberg RM; O'Connell MJ; Benedetti JK; Saltz LB; Dignam JJ; Blackstock AW;
    J Natl Cancer Inst; 2011 Oct; 103(20):1498-506. PubMed ID: 21997132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.